First Light Asset Management, LLC 13F holdings, Q1 2026
Holdings as of March 31, 2026 · filings on SEC EDGAR · latest filing →
First Light Asset Management, LLC disclosed 35 US equity positions worth $1.1bn in its Q1 2026 13F filing. The largest position was AXGN at 11.9% of the reported book, followed by PVLA and NEO.
What did First Light Asset Management, LLC own in Q1 2026? Top 35 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | AXGN AXOGEN INC | Healthcare | 11.9% | $132.6m | 4,002,768 | – | |
| 2 | PVLA PALVELLA THERAPEUTICS INC | Healthcare | 11.0% | $122.3m | 980,758 | – | |
| 3 | NEO NEOGENOMICS INC | Healthcare | 6.5% | $72.2m | 9,729,978 | – | |
| 4 | SIBN SI-BONE INC | Healthcare | 6.1% | $67.6m | 5,353,190 | – | |
| 5 | CNTA CENTESSA PHARMACEUTICALS LIMITED | 5.6% | $62.0m | 1,560,991 | – | ||
| 6 | APGE APOGEE THERAPEUTICS INC | Healthcare | 4.3% | $48.5m | 576,684 | – | |
| 7 | AMLX AMYLYX PHARMACEUTICALS INC | Healthcare | 4.0% | $44.3m | 3,190,645 | – | |
| 8 | TWST TWIST BIOSCIENCE CORPORATION | Healthcare | 3.7% | $41.8m | 878,848 | – | |
| 9 | CRNXGBP CRINETICS PHARMACEUTICALS INC | 3.5% | $39.6m | 1,089,670 | – | ||
| 10 | MASS 908 DEVICES INC | 3.3% | $37.2m | 6,072,563 | – | ||
| 11 | NPCE NEUROPACE INC | 2.9% | $32.3m | 2,459,966 | – | ||
| 12 | EWTX EDGEWISE THERAPEUTICS INC | Healthcare | 2.8% | $31.6m | 1,001,846 | – | |
| 13 | ANAB ANAPTYS BIO INC | Healthcare | 2.8% | $31.4m | 565,431 | – | |
| 14 | SLP SIMULATIONS PLUS INC | Healthcare | 2.8% | $31.1m | 2,632,823 | – | |
| 15 | GH GUARDANT HEALTH | Healthcare | 2.3% | $25.9m | 280,299 | – | |
| 16 | TNDM TANDEM DIABETES CARE INC | Healthcare | 2.3% | $25.2m | 1,314,715 | – | |
| 17 | ATRC ATRICURE INC | Healthcare | 1.9% | $20.8m | 729,521 | – | |
| 18 | TLSI TRISALUS LIFE SCIENCES INC | 1.8% | $20.3m | 5,066,827 | – | ||
| 19 | TECX TECTONIC THERAPEUTICS INC | Healthcare | 1.8% | $20.0m | 647,743 | – | |
| 20 | IRTC IRHYTHM TECHNOLOGIES | Healthcare | 1.8% | $19.8m | 168,116 | – | |
| 21 | SEPN SEPTERNA INC | Healthcare | 1.6% | $17.6m | 732,860 | – | |
| 22 | ESTA ESTABLISHMENT LABS HOLDINGS | Healthcare | 1.6% | $17.5m | 307,738 | – | |
| 23 | HCAT HEALTH CATALYST INC | Healthcare | 1.5% | $16.4m | 12,878,700 | – | |
| 24 | OMCL OMNICELL INC | Healthcare | 1.5% | $16.4m | 489,846 | – | |
| 25 | KRMD KORU MEDICAL SYSTEMS INC | 1.5% | $16.3m | 3,768,380 | – | ||
| 26 | WGS GENEDX HOLDINGS CORP | Healthcare | 1.4% | $15.6m | 242,927 | – | |
| 27 | WVE WAVE LIFE SCIENCES LTD | Healthcare | 1.2% | $13.4m | 1,843,968 | – | |
| 28 | VERA VERA THERAPEUTICS INC | Healthcare | 1.1% | $12.6m | 313,906 | – | |
| 29 | MDXG MIMEDX GROUP INC | Healthcare | 1.0% | $11.2m | 2,842,892 | – | |
| 30 | BFLY BUTTERFLY NETWORK INC | Healthcare | 1.0% | $10.7m | 2,660,167 | – | |
| 31 | SPYGLASS PHARMA INC | 0.9% | $9.7m | 375,000 | – | ||
| 32 | ORGO ORGANOGENESIS HOLDINGS INC | Healthcare | 0.7% | $8.3m | 3,498,533 | – | |
| 33 | PCVX VAXCYTE INC | Healthcare | 0.7% | $8.2m | 141,784 | – | |
| 34 | ELVN ENLIVEN THERAPEUTICS INC | Healthcare | 0.7% | $7.9m | 201,867 | – | |
| 35 | RYTM RHYTHM PHARMACEUTICALS INC | Healthcare | 0.7% | $7.6m | 87,181 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.